HSBC HOLDINGS PLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$122,000
+8.9%
44,407
+125.4%
0.00%
Q1 2022$112,000
-57.4%
19,698
+20.8%
0.00%
Q1 2021$263,000
+6.0%
16,308
+39.0%
0.00%
Q4 2020$248,000
+45.0%
11,730
-20.1%
0.00%
Q1 2020$171,000
-40.6%
14,683
+20.0%
0.00%
-100.0%
Q4 2019$288,000
+32.7%
12,240
+4.3%
0.00%
Q3 2019$217,000
-19.0%
11,730
+7.1%
0.00%
Q1 2019$268,00010,9560.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders